Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DUSP10 |
| Upstream (Parents) |
|---|
| (<<) ATIC → DUSP10 |
| (<<) CDK4 → DUSP10 |
| (<<) CEBPD → DUSP10 |
| (<<) ELF4 → DUSP10 |
| (<<) HSD17B2 → DUSP10 |
| (<<) IGFBP3 → DUSP10 |
| (<<) KLF11 → DUSP10 |
| (<<) MAT2A → DUSP10 |
| (<<) MIA3 → DUSP10 |
| (<<) MT1G → DUSP10 |
| (<<) MYC → DUSP10 |
| (<<) NUDT6 → DUSP10 |
| (<<) RAC1 → DUSP10 |
| (<<) RNASE4 → DUSP10 |
| (<<) SHC2 → DUSP10 |
| Downstream (Children) |
|---|
| DUSP10 → ADAM8 (>>) |
| DUSP10 → CDH3 (>>) |
| DUSP10 → ETS1 (>>) |
| DUSP10 → GNE (>>) |
| DUSP10 → LIPG (>>) |
| DUSP10 → LPIN1 (>>) |
| DUSP10 → MVK (>>) |
| DUSP10 → PLCG1 (>>) |
| DUSP10 → PRKAB1 (>>) |
| DUSP10 → PRKCD (>>) |
| DUSP10 → RAB22A (>>) |
| DUSP10 → SLPI (>>) |
| DUSP10 → T (>>) |
| DUSP10 → TK2 (>>) |
| DUSP10 → TMSB10 (>>) |
| DUSP10 → VAV3 (>>) |
